Clinical Trials Logo

Clinical Trial Summary

Several reports have shown the utility of PVC ablation with cryo catheters. The aim of this study is to compare the outcomes and safety of Cryo vs. RF for PVCs.


Clinical Trial Description

Background: Radiofrequency (RF) catheter ablation (CA) is an effective therapeutic strategy in eliminating refractory idiopathic ventricular outflow tract (OT) ventricular arrhythmias (VA). However, early and late recurrences occur commonly. RFCA has also been reported to be associated with collateral damage and pain. The use of Cryo ablation as a safer alternative energy source been previously described. In several reports Cryo was reported to successfully treat VA originating from the OT in the absence of ablation related pain and collateral damage to adjacent structures such as the coronaries. When comparing outcomes and complications of catheter ablation of VA from the papillary muscles of the left ventricle with either Cryo or RF, Cryo was found to be associated with significantly higher success rates and lower recurrence rates than RFCA.

Aim: To compare the outcomes and safety of Cryo vs. RF for PVCs. Methods: Patients with PVC VA will be randomized in a 1:1 fashion to RFCA or Cryo ablation. All procedures will be done using a 3-dimensional mapping system (EnSite™ NavX™ system, St. Jude Medical). Ablation will be performed at sites with earliest activation or at least pacemap exhibiting QRS morphology match of >11/12. Endpoint of procedure will be elimination and non inducibility of the clinical VA. All patients will undergo continuous monitoring for at least 12 hours post procedure and 12 lead Holter and exercise testing 1 month post procedure. Successful ablation will be defined as absence of clinical VA or > 50% reduction in arrhythmia burden on Holter in the absence of anti-arrhythmic medications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03086902
Study type Interventional
Source Sheba Medical Center
Contact Eyal Nof, MD
Phone +9725302604
Email eyal.nof@sheba.health.gov.il
Status Not yet recruiting
Phase N/A
Start date December 2018
Completion date July 2021

See also
  Status Clinical Trial Phase
Completed NCT03370679 - The Prognostic Significance of Premature Ventricular Complexes in Patients Without Structural Heart Disease N/A
Completed NCT04884100 - enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening N/A
Not yet recruiting NCT04990089 - VIVO European Observational Registry
Not yet recruiting NCT06110364 - Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions Phase 3
Completed NCT04171479 - RMN Versus Manual Epicardial Retrospective PMCF
Not yet recruiting NCT04519112 - Remote Magnetic Versus Manual Navigation-guided Ablation for Non-outflow Tract Premature Ventricular Contractions: a Prospective, Randomized, Controlled Trial Phase 4
Recruiting NCT01235156 - Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions Phase 2
Recruiting NCT05866731 - The Heart Rhythm Twins Study
Recruiting NCT04909528 - LLTS to Treat Premature Ventricular Contractions N/A
Not yet recruiting NCT06327425 - MCG for Localization of Tachyarrhythmia's Origin N/A
Completed NCT03340142 - VIVO™ Accuracy Study N/A
Completed NCT05008250 - Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex. Phase 4
Completed NCT02666742 - DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation Phase 4
Completed NCT03447002 - Urine Levels of Metanephrin and Normetanephrin in Patients With Frequent Ventricular Premature Complex
Withdrawn NCT04219501 - Ventricular Arrhythmia Ablation With the Use of Non-Invasive ECG Imaging Technology N/A
Recruiting NCT05341544 - Non-invasive Vagal Stimulation for Frequent Premature Ventricular Complexes N/A
Enrolling by invitation NCT01750775 - Shensongyangxin Capsule in the Treatment of Sinus Bradycardia With Premature Ventricular Contractions Phase 4
Completed NCT05167058 - Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm
Terminated NCT03288766 - SHERLOCK 3CG™ Diamond Tip Confirmation System